Samuel J. Moed
CIK: 0001561017
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SCNI
Scinai Immunotherapeutics Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Moed Samuel J
Moed Samuel J (SEC CIK 0001561017) files insider reports with the SEC as Director of Scinai Immunotherapeutics Ltd. (SCNI).
Signal8 holds 1 ownership filing by Moed Samuel J, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Moed Samuel J's filings is in JERUSALEM.
Other insiders filing for Scinai Immunotherapeutics Ltd. (SCNI)
- GERMAIN MARK, Director
- Reichman Amir, Chief Executive Officer
- Mark Elad, Chief Operating Officer
- MARGOLIN YAEL, Director
- Ben-Or Uri, Director
- Green Jay, Director